Zeitschrift fur Neurologie, 1432-1459

Journal

More filtering options
More filtering options

All authors

Reset
to
1 - 32 out of 32Page size: 50
  1. 2019

  2. Vestibular rehabilitation therapy in Europe: chances and challenges

    Vestibular Rehabilitation Research Group in the European DIZZYNET, Jahn, K., Lopez, C., Zwergal, A., Zur, O., Cakrt, O., Kellerer, S., Kerkeni, H., Tjernström, F. & Meldrum, D., 2019 May 17, In : Journal of Neurology.

    Research output: Contribution to journal › Letter

  3. 2018

  4. Dizziness in Europe: from licensed fitness to drive to licence without fitness to drive

    Huppert, D., Straumann, D., Mans Magnusson, Pyykkö, I. & Brandt, T., 2018, In : Journal of Neurology. 265, S1, p. 9-17

    Research output: Contribution to journal › Article

  5. The clinical significance of 10-m walk test standardizations in Parkinson’s disease

    Beata Lindholm, Maria H. Nilsson, Oskar Hansson & Hagell, P., 2018, In : Journal of Neurology. 265, 8, p. 1829-1835

    Research output: Contribution to journal › Article

  6. 2016

  7. External validation of a 3-step falls prediction model in mild Parkinson’s disease

    Beata Lindholm, Maria H. Nilsson, Oskar Hansson & Hagell, P., 2016 Dec, In : Journal of Neurology. 263, 12, p. 2462-2469

    Research output: Contribution to journal › Article

  8. DIZZYNET: the European network for vertigo and balance research: visions and aims

    Zwergal, A., Brandt, T., Måns Magnusson & Kennard, C., 2016 Apr 15, In : Journal of Neurology. 263

    Research output: Contribution to journal › Debate/Note/Editorial

  9. Current concepts and future approaches to vestibular rehabilitation

    Tjernström, F., Zur, O. & Jahn, K., 2016 Apr 1, In : Journal of Neurology. 263, suppl. 1, p. 65-70 6 p.

    Research output: Contribution to journal › Review article

  10. DIZZYNET - a European network initiative for vertigo and balance research: visions and aims

    Zwergal, A., Brandt, T., Måns Magnusson & Kennard, C., 2016 Apr, In : Journal of Neurology. 263, Suppl 1, p. 2-9

    Research output: Contribution to journal › Review article

  11. The neurology community mourns the passing of Dr. John F. Kurtzke

    Filippi, M., Barker, R. A. & Strupp, M., 2016 Mar, In : Journal of Neurology. 263, 3, p. 421

    Research output: Contribution to journal › Debate/Note/Editorial

  12. Frequency of MELAS main mutation in a phenotype-targeted young ischemic stroke patient population.

    Tatlisumak, T., Putaala, J., Innilä, M., Enzinger, C., Metso, T. M., Curtze, S., von Sarnowski, B., Amaral-Silva, A., Jungehulsing, G. J., Tanislav, C., Thijs, V., Rolfs, A., Bo Norrving, Fazekas, F., Suomalainen, A. & Kolodny, E. H., 2016, In : Journal of Neurology. 263, 2, p. 257-262

    Research output: Contribution to journal › Article

  13. 2015

  14. Progress in Huntington's disease: the search for markers of disease onset and progression

    Mason, S. & Barker, R. A., 2015 Aug, In : Journal of Neurology. 262, 8, p. 1990-5 6 p.

    Research output: Contribution to journal › Article

  16. Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement

    Albanese, A., Abbruzzese, G., Dressler, D., Duzynski, W., Khatkova, S., Jose Marti, M., Mir, P., Montecucco, C., Moro, E., Pinter, M., Relja, M., Roze, E., Skogseid, I. M., Timerbaeva, S. & Tzoulis, C., 2015, In : Journal of Neurology. 262, 10, p. 2201-2213

    Research output: Contribution to journal › Review article

  17. 2013

  18. The Addenbrooke's Cognitive Examination-Revised accurately detects cognitive decline in Huntington's disease

    Begeti, F., Tan, A. Y. K., Cummins, G. A., Collins, L. M., Guzman, N. V., Mason, S. L. & Barker, R. A., 2013 Nov, In : Journal of Neurology. 260, 11, p. 2777-85

    Research output: Contribution to journal › Article

  19. 2012

  20. Gender-related differences in the burden of non-motor symptoms in Parkinson's disease

    Martinez-Martin, P., Pecurariu, C. F., Per Odin, van Hilten, J. J., Antonini, A., Rojo-Abuin, J. M., Borges, V., Trenkwalder, C., Aarsland, D., Brooks, D. J. & Chaudhuri, K. R., 2012, In : Journal of Neurology. 259, 8, p. 1639-1647

    Research output: Contribution to journal › Article

  21. Psychometric performance of a generic walking scale (Walk-12G) in multiple sclerosis and Parkinson's disease.

    Jonasson, S., Maria H Nilsson, Hariz, G-M., Westergren, A., Hobart, J. & Hagell, P., 2012, In : Journal of Neurology. 259, Sep 29, p. 729-738

    Research output: Contribution to journal › Article

  22. 2010

  23. ADAMTS13 may be neuroprotective against brain ischaemia-reperfusion injury by improving post-ischaemic microcirculation and inflammation

    Fujioka, M., Hayakawa, K., Mishima, K., Kunizawa, A., Muroi, C., Irie, K., Higuchi, S., Nakano, T., Banno, F., Kokame, K., Miyata, T., Yonekawa, Y., Sakaki, T., Nishio, K., Okuchi, K., Fujiwara, M. & Siesjö, B., 2010, In : Journal of Neurology. 257, Suppl. 1, p. O135

    Research output: Contribution to journal › Published meeting abstract

  24. Associations between annualized relapse rate and long-term exposure to subcutaneous interferon beta-1a in the Prevention of Relapses and disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis (PRISMS) long-term follow-up study

    Uitdehaag, B., Constantinescu, C., Cornelisse, P., Jeffery, D., Kappos, L., Li, D., Sandberg Wollheim, M., Traboulsee, A., Verdun, E. & Rivera, V., 2010, In : Journal of Neurology. 257, Suppl. 1, p. P456

    Research output: Contribution to journal › Published meeting abstract

  25. Evaluation of the risk of malignancy in patients with multiple sclerosis treated with subcutaneous interferon beta-1a

    Sandberg Wollheim, M., Kornmann, G., Moraga, M., Miret, M. & Alteri, E., 2010, In : Journal of Neurology. 257, Suppl. 1, p. O44

    Research output: Contribution to journal › Published meeting abstract

  26. 2009

  27. A decision tool to support appropriate referral for deep brain stimulation in Parkinson's disease

    Moro, E., Allert, N., Eleopra, R., Houeto, J-L., Phan, T-M., Stoevelaar, H. & International Study Group on Referral Criteria for DBS, 2009 Jan, In : Journal of Neurology. 256, 1, p. 83-8 6 p.

    Research output: Contribution to journal › Article

  28. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation

    Unden, J., Strandberg, K., Malm, J., Campbell, E., Rosengren, L., Johan Stenflo, Bo Norrving, Romner, B., Lindgren, A. & Andsberg, G., 2009, In : Journal of Neurology. 256, 1, p. 72-77

    Research output: Contribution to journal › Article

  30. 2008

  32. Delayed neurodegeneration in the pulvinar and medial dorsal nuclei of the human thalami on diffusion-weighted MRI after hypoglycaemic injury ( Eighteenth Meeting of the European Neurological Society 7–11 June 2008, Nice, France)

    Kunizawa, A., Suzuki, S., Kitazawa, Y., Asai, A., Kawamoto, K., Ickenstein, G. W., Siesjö, B. & Fujioka, M., 2008, In : Journal of Neurology. 255, Suppl. 2, p. 83-83

    Research output: Contribution to journal › Published meeting abstract

  33. Migrainous incomplete infarction ( Eighteenth Meeting of the European Neurological Society 7–11 June 2008, Nice, France)

    Kunizawa, A., Suzuki, S., Asai, A., Kawamoto, K., Kitazawa, Y., Ickenstein, G. W., Siesjö, B. & Fujioka, M., 2008, In : Journal of Neurology. 255, Suppl. 2, p. 156-157

    Research output: Contribution to journal › Published meeting abstract

  34. Testing the SF-36 in Parkinson's disease : Implications for reporting rating scale data.

    Hagell, P., Törnqvist, A. L. & Hobart, J., 2008, In : Journal of Neurology. 255, 2, p. 246-254

    Research output: Contribution to journal › Article

  35. 2007

  36. One-year follow-up of cognitive behavioral therapy for phobic postural vertigo

    Holmberg, J., Mikael Karlberg, Harlacher, U. & Måns Magnusson, 2007, In : Journal of Neurology. 254, 9, p. 1189-1192

    Research output: Contribution to journal › Article

  37. 2006

  38. Treatment of phobic postural vertigo A controlled study of cognitive-behavioral therapy and self-controlled desensitization.

    Holmberg, J., Mikael Karlberg, Harlacher, U., Rivano-Fischer, M. & Måns Magnusson, 2006, In : Journal of Neurology. 253, 4, p. 500-506

    Research output: Contribution to journal › Article

  39. 2005

  40. Adolf Wallenberg (1862-1949)

    Hyden, D. & Bo Norrving, 2005, In : Journal of Neurology. 252, 9, p. 1135-1136

    Research output: Contribution to journal › Letter

  41. Comparative tolerance of IFN beta-1a regimens in patients with relapsing multiple sclerosis The EVIDENCE study.

    Sandberg Wollheim, M., Bever, C., Carter, J., Färkkilä, M., Hurwitz, B., Lapierre, Y., Chang, P. & Francis, G. S., 2005, In : Journal of Neurology. 252, 1, p. 41499

    Research output: Contribution to journal › Article

  42. Predicting the Outcome of Optic Neuritis Evaluation of risk factors after 30 years of follow-up.

    Nilsson, P., Larsson, E-M., Maly-Sundgren, P., Perfekt, R. & Sandberg Wollheim, M., 2005, In : Journal of Neurology. 252, 4, p. 396-402

    Research output: Contribution to journal › Article

  43. 2004

  44. Diffusion tensor MRI post mortem demonstrated cerebral white matter pathology.

    Elisabet Englund, Martin Sjöbeck, Brockstedt, S., Jimmy Lätt & Larsson, E-M., 2004, In : Journal of Neurology. 251, 3, p. 350-352

    Research output: Contribution to journal › Letter

  45. 1986

  46. Anti-herpes simplex type 1 activity in IgG subclasses produced systemically and intrathecally in patients with herpes encephalitis

    Johansson, H. & Blomberg, J., 1986, In : Journal of Neurology. 233, 5, p. 289-296

    Research output: Contribution to journal › Article